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The recent  statement  by Hebestreit  and colleagues  [1]  on behalf  of  the European Cystic 
Fibrosis Society (ECFS) Exercise Working Group and endorsed by the European Respiratory 
Society,  should be commended for  their  efforts  to  establish consensus regarding exercise 
testing for young people with CF. Exercise testing is a valuable investigative tool within both 
the clinical management and scientific investigation of children and adolescents with CF and 
this  document  provides  an  international  standpoint  regarding  the  importance  of 
comprehensive cardiopulmonary exercise testing (CPET) within the clinical management of 
this patient group. However, it is our view that the authors have missed an opportunity to 
provide a contemporary overview of the CPET ‘toolkit’ currently available.  
The  authors  state  that  this  document  will  ‘describe  the  current  best  practice  
recommendations for  conducting exercise tests  in  patients  with CF’ and  ‘summarises  the  
information  available  on  specific  test  protocols  and outcome parameters  (Page 2)’.  The 
authors recommend the Godfrey protocol [2] when using the cycle ergometer, with measures 
of arterial oxygen saturation and, when possible, pulmonary gas exchange and ventilation. 
Whilst this does represent progress from the routinely used shuttle and step tests, the authors 
failed  to  acknowledge  several  limitations  inherent  to  the  Godfrey  protocol  and  the 
recommended use of criteria to verify a maximal test. This is surprising, given that the ECFS 
Clinical Trials Network Standardisation Committee recently called for research assessing the 
validity,  reproducibility and feasibility of outcome measures utilised in the assessment of 
patients with CF and the most appropriate exercise test for paediatric patients [3]. 
The authors rightfully acknowledge that an issue with shuttle and step tests is that it can be 
difficult to determine whether a maximal effort was made. However, they then state that ‘the 
Godfrey protocol provides valid information for all CF relevant indications for an exercise  
test’. The authors recommend that since not all individuals display the tradition verification 
criterion of a plateau in oxygen uptake (VO2) upon exhaustion, at least one of the following 
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should be used to confirm a maximal effort: the patient achieves a predicted VO2peak or peak 
power output (Wpeak);  the patient reaches maximal heart  rate,  peak ventilation approaches 
maximal voluntary ventilation, respiratory exchange ratio (RER) is > 1.03, exertion is 9-10 
on the 0-10 scale or ≥17 on a 7-20 scale. However, our research group recently demonstrated 
that the use of secondary criteria to confirm a maximal effort (e.g. RER > 1.00 or 1.10, [blood 
lactate]  ≥  6  mmolL-1),  as  recommended  by  Hebestreit  et  al.  [1],  are  invalid  and  can 
drastically  underreport  maximal  VO2max in  some  young  people  with  CF  [4],  a  finding 
consistent  with  healthy  children  and  adolescents  [5].  Accepting  submaximal  or  rejecting 
‘true’ maximal values could distort  the clinical application and interpretation of CPET in 
young people with CF. 
We have,  however,  demonstrated  that  a  procedure  termed the  ‘supramaximal  verification 
phase’  (Smax),  in  which  an  exhaustive  ramp  incremental  test  precedes  an  exhaustive 
individualised constant work rate test at an intensity above Wpeak, can confirm a whether a 
‘true’ measure  of  VO2max has  been  obtained,  which  is  fundamental  to  the  utility  of  this 
outcome parameter in CF. This finding is in line with data in healthy adults [6-14], children 
[5]  and  other  paediatric  clinical  groups  [15].  Although  the  authors  present  information 
regarding  ‘was  the  test  maximal?’, they  failed  to  mention  this  published  evidence  and 
presented inaccurate verification criteria as  best CPET practice for young people with CF, 
which should be approached with caution. This statement also provides a summary of the 
reliability of exercise tests for young people with CF, however again recent evidence has been 
ignored.  We recently reported both the short-  and medium-term reproducibility of a valid 
CPET protocol for young people with CF [16],  which was shown to reduce the error of 
measurement when compared with an isolated incremental CPET to derived VO2peak [16]. 
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Whilst the focus of this letter addresses validity and reproducibility issues with the Godfrey 
protocol,  other  potential  issues  to  consider  are:  ‘step’  increases  in  work  rate  derived 
exclusively from stature can result  in insufficient  test  durations of ≤ 4 minutes  in young 
people with CF [17], which limits our ability to characterise the progressive increase in VO2 
during exercise and determine submaximal measures of aerobic fitness (e.g. the gas exchange 
threshold or VO2 mean response time) which, as highlighted in this consensus statement, may 
provide better predictors of mortality in adolescents with CF [18]. In accordance with others 
[19],  we  therefore  recommend  a  ramp  incremental  exercise  test,  which  aims  to  reach 
volitional exhaustion in 8-12 minutes [20], followed by Smax verification of maximal CPET 
parameters.  Not  only has  this  testing protocol  been demonstrated  as  safe and feasible  in 
young people with CF in a research setting, it is also now used as part of patients’ annual 
clinical  review  with  UK  based  CF  clinics  in  Exeter,  Southampton  and  Portsmouth, 
demonstrating the feasibility of its clinical implementation. The CF-specific linear regression 
model to predict Wpeak and calculate individualised workload increments to reach volitional 
exhaustion in ~ 10 minutes developed by Hulzebos and colleagues should help prevent short 
test durations [21].
Whilst it is recognised that there are not currently any large scale studies directly comparing 
exercise testing protocols, we feel the authors could have provided a more contemporary 
overview of  the  evidence  concerning  the  validity  and  reproducibility  of  CPET protocols 
available  for  use  in  young  people  with  CF.  If  the  clinical  utility  of  CPET to  provide  a 
comprehensive evaluation of physiological (dys)function and stratify patients with CF is to be 
realised, these important practical considerations much be acknowledged. 
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